Gyre Therapeutics (GYRE) Depreciation and Depletion (2025 - 2026)

Gyre Therapeutics (GYRE) Depreciation and Depletion (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Depreciation and Depletion (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	2.10 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	38.91 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	3.18 Mn
10	Gyre Therapeutics	708.31 Mn	685.47 Mn	26.90 Mn	1.10 Mn

Download Data